Influenza type B, though generally less widespread than type A, poses a formidable threat for vulnerable populations like the elderly and the young. In the 2012-2013 flu season, for example, influenza type B caused the majority of deaths due to flu among children, according to data from the CDC. New findings suggest that an efficient way to boost the efficacy of vaccines against influenza type B might be hiding in plain sight.